Back to News
Market Impact: 0.25
DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
Source: Newswire
Consumer Demand & RetailProduct LaunchesCompany FundamentalsHealthcare & Biotech
September 2026 revenue increased more than 66% versus July 2026, driven by an expanding retail customer base and launches of Tollo Health pharmaceutical-adjunct products. The update signals strong near-term commercial momentum, though no absolute revenue figures, profitability metrics, or forward guidance were provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.48
Ticker Sentiment
HEALTH0.78
More News
- Broadcom to lend Anthropic up to $42 billion to lease its chips, filing says
- Nike Warns Sales Slump Will Worsen This Fiscal Year
- $8.2B acquisition validates AI-picked chip stock: +20% since June
- Nuveen CEO on Schroders Deal, Plans for Combined Company
- New Mexico wants Meta to pay up to $40 billion in penalties after data privacy trial
- Markets slip on dollar pressure, but this IT stock is up 10% today
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Capital Intensity as Gravity: The AI Trade Enters Its Industrial Era (Looking at Q3 2025 Earnings in Tech)
- AI Portfolio Monitoring: Build an Alert Policy Analysts Can Audit